Center for Quality, Effectiveness, and Outcomes in Cardiovascular Diseases, Houston, TX; Department of Anesthesia, Long School of Medicine, San Antonio, TX.
Center for Quality, Effectiveness, and Outcomes in Cardiovascular Diseases, Houston, TX; Department of Vascular/Endovascular Surgery, Ascension Health, Waco, TX.
Ann Vasc Surg. 2024 Sep;106:467-478. doi: 10.1016/j.avsg.2024.04.003. Epub 2024 May 28.
Infra-popliteal interventions for chronic limb-threatening ischemia (CLTI) can be impacted by the morphology of the tibial vessels. The aim of this study was to examine the impact of a novel morphology-driven classification on the outcomes of isolated tibial intervention for CLTI.
A database of patients undergoing isolated tibial interventions for CLTI at a single center between 2010 and 2020 was retrospectively queried. Patients with isolated infra-popliteal disease were identified, and their anatomy was scored as present or absent for lesion calcification (1 point), target vessel diameter<3.0 mm (1 point), lesion length>300 mm (1 point), and poor pedal runoff score (1 point). Patients were then divided into 3 groups: low risk (0 or 1 points), moderate risk (2 points), and high risk (3 or 4 points). Intention to treat analysis by the patient was performed. Limb-based patency (the absence of reintervention, occlusion, critical stenosis [>70%], or hemodynamic compromise with ongoing symptoms of CLTI as it related to the patency of the preoperatively determined target artery pathway) was assessed. Patient-oriented outcomes of amputation-free survival (AFS; survival without major amputation) and freedom from major adverse limb events (MALE; above ankle amputation of the index limb or major reintervention: new bypass graft, jump/interposition graft revision) were evaluated.
1,607 patients (55% male, average age 60 years, 3,846 vessels) underwent tibial intervention for CLTI. The majority of the patients were diabetic and of Hispanic origin. Morphologically, 27%, 31%, and 42% of the vessels were categorized as low risk, moderate risk, and high risk, respectively. There was a significant worsening of the infra-popliteal Global Limb Anatomic Staging System (GLASS) grading as the morphological risk increased. The 30-day major adverse cardiac events (MACE) were equivalent across the groups and were under the stated objective performance goal (OPG) of ≤10%. In contrast, both the 30-day MALE and the 30-day major amputations were significantly different across the groups, with the low-risk group remaining under the OPG of ≤9% and ≤4%, respectively, while the moderate risk and high risk exceeded the goal threshold. For the OPG, freedom from MALE was 60 ± 5%, 46 ± 5%, and 22 ± 9% at 5 years for low-, moderate-, and high-risk groups, respectively (mean ± standard error of the mean; P = 0.008). Overall AFS was 55 ± 5%, 37 ± 6%, and 18 ± 7% at 5 years for low-, moderate-, and high-risk groups, respectively (mean ± standard error of the mean; P = 0.003).
Tibial anatomic morphology impacts isolated tibial endovascular intervention with adverse morphology associated with poorer short- and long-term outcomes. Risk stratification based on anatomic predictors should be an additional consideration as one intervenes on infra-popliteal vessels for CLTI.
慢性肢体严重缺血(CLTI)的腘下血管介入治疗可能受到胫骨血管形态的影响。本研究旨在检查一种新的形态驱动分类对 CLTI 孤立性胫骨介入治疗结果的影响。
回顾性查询了 2010 年至 2020 年期间在一家中心接受孤立性胫骨介入治疗 CLTI 的患者数据库。确定了有孤立性腘下疾病的患者,并对其解剖结构进行评分,是否存在病变钙化(1 分)、靶血管直径<3.0mm(1 分)、病变长度>300mm(1 分)和较差的足背血流评分(1 分)。然后,患者被分为 3 组:低危(0 或 1 分)、中危(2 分)和高危(3 或 4 分)。通过患者意向治疗进行分析。评估基于肢体的通畅率(无再介入、闭塞、临界狭窄[>70%]或血流动力学受损,伴有 CLTI 的持续症状,与术前确定的靶动脉通路通畅率有关)。评估患者导向的无截肢生存率(AFS;无主要截肢的生存)和免于主要不良肢体事件(MALE;指数肢体的踝上截肢或主要再介入:新旁路移植、跳跃/中间移植再修复)的情况。
1607 名患者(55%为男性,平均年龄 60 岁,3846 条血管)接受了 CLTI 的胫骨介入治疗。大多数患者患有糖尿病且为西班牙裔。形态上,27%、31%和 42%的血管分别被归类为低危、中危和高危。随着形态风险的增加,腘下全球肢体解剖分期系统(GLASS)的分级显著恶化。各组之间 30 天主要不良心脏事件(MACE)无显著差异,且均低于规定的目标绩效目标(OPG)≤10%。相比之下,30 天的 MALE 和 30 天的主要截肢在各组之间均有显著差异,低危组保持在 OPG 规定的≤9%和≤4%,而中危组和高危组超过了目标阈值。OPG 规定,低、中、高危组的 5 年无 MALE 率分别为 60±5%、46±5%和 22±9%(平均值±标准误差;P=0.008)。总体 AFS 分别为 55±5%、37±6%和 18±7%,低、中、高危组的 5 年生存率分别为(平均值±标准误差;P=0.003)。
胫骨解剖形态影响孤立性胫骨血管内治疗,不良形态与短期和长期预后较差有关。基于解剖预测因子的风险分层应作为 CLTI 腘下血管介入治疗的额外考虑因素。